Align Technology, Inc. (0HCK.L)
USD 180.07
(0.37%)
USD 180.07
(0.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 296.9 Million USD | -12.35% |
| 2022 | 338.75 Million USD | 47.14% |
| 2021 | 230.23 Million USD | 65.35% |
| 2020 | 139.23 Million USD | 24.26% |
| 2019 | 112.05 Million USD | 101.38% |
| 2018 | 55.64 Million USD | 75.59% |
| 2017 | 31.68 Million USD | 16.8% |
| 2016 | 27.13 Million USD | 39.38% |
| 2015 | 19.46 Million USD | 22.21% |
| 2014 | 15.92 Million USD | 14.03% |
| 2013 | 13.96 Million USD | -7.63% |
| 2012 | 15.12 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 280.07 Million USD | -5.67% |
| 2024 Q3 | 254.11 Million USD | -2.07% |
| 2024 Q2 | 259.49 Million USD | -7.35% |
| 2023 Q2 | 312.73 Million USD | 0.27% |
| 2023 Q1 | 311.88 Million USD | -7.93% |
| 2023 FY | 296.9 Million USD | -12.35% |
| 2023 Q4 | 296.9 Million USD | 0.24% |
| 2023 Q3 | 296.18 Million USD | -5.29% |
| 2022 Q3 | 320.9 Million USD | 3.5% |
| 2022 Q2 | 310.04 Million USD | 12.47% |
| 2022 Q1 | 275.66 Million USD | 19.74% |
| 2022 FY | 338.75 Million USD | 47.14% |
| 2022 Q4 | 338.75 Million USD | 5.56% |
| 2021 Q1 | 150.64 Million USD | 8.19% |
| 2021 FY | 230.23 Million USD | 65.35% |
| 2021 Q4 | 230.23 Million USD | 11.16% |
| 2021 Q3 | 207.11 Million USD | 15.87% |
| 2021 Q2 | 178.75 Million USD | 18.66% |
| 2020 Q4 | 139.23 Million USD | 13.12% |
| 2020 Q1 | 120.97 Million USD | 7.97% |
| 2020 Q3 | 123.09 Million USD | -6.23% |
| 2020 Q2 | 131.27 Million USD | 8.51% |
| 2020 FY | 139.23 Million USD | 24.26% |
| 2019 Q1 | 68.48 Million USD | 23.09% |
| 2019 FY | 112.05 Million USD | 101.38% |
| 2019 Q4 | 112.05 Million USD | 18.2% |
| 2019 Q3 | 94.79 Million USD | 16.85% |
| 2019 Q2 | 81.12 Million USD | 18.45% |
| 2018 Q2 | 47.25 Million USD | 31.75% |
| 2018 Q3 | 48.85 Million USD | 3.4% |
| 2018 Q4 | 55.64 Million USD | 13.88% |
| 2018 FY | 55.64 Million USD | 75.59% |
| 2018 Q1 | 35.86 Million USD | 13.18% |
| 2017 Q1 | 35.17 Million USD | 29.65% |
| 2017 FY | 31.68 Million USD | 16.8% |
| 2017 Q4 | 31.68 Million USD | -14.22% |
| 2017 Q3 | 36.94 Million USD | 5.15% |
| 2017 Q2 | 35.13 Million USD | -0.12% |
| 2016 Q4 | 27.13 Million USD | 3.0% |
| 2016 FY | 27.13 Million USD | 39.38% |
| 2016 Q3 | 26.34 Million USD | 14.57% |
| 2016 Q2 | 22.99 Million USD | 1.65% |
| 2016 Q1 | 22.61 Million USD | 16.2% |
| 2015 FY | 19.46 Million USD | 22.21% |
| 2015 Q4 | 19.46 Million USD | 2.78% |
| 2015 Q3 | 18.93 Million USD | 15.38% |
| 2015 Q2 | 16.41 Million USD | 12.65% |
| 2015 Q1 | 14.57 Million USD | -8.51% |
| 2014 Q1 | 15.84 Million USD | 13.4% |
| 2014 Q4 | 15.92 Million USD | -0.34% |
| 2014 FY | 15.92 Million USD | 14.03% |
| 2014 Q3 | 15.98 Million USD | 21.87% |
| 2014 Q2 | 13.11 Million USD | -17.2% |
| 2013 FY | 13.96 Million USD | -7.63% |
| 2013 Q3 | 14.66 Million USD | -6.64% |
| 2013 Q4 | 13.96 Million USD | -4.73% |
| 2013 Q1 | 15.44 Million USD | 2.12% |
| 2013 Q2 | 15.7 Million USD | 1.7% |
| 2012 Q4 | 15.12 Million USD | 0.0% |
| 2012 FY | 15.12 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -114.642% |
| Elevance Health Inc. | -46.33 Billion USD | 100.641% |
| AxoGen, Inc. | 23.02 Million USD | -1189.757% |
| Boston Scientific Corporation | 2.48 Billion USD | 88.047% |
| CVS Health Corporation | 18.02 Billion USD | 98.353% |
| Cardinal Health, Inc. | 14.95 Billion USD | 98.015% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -107.471% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 85.309% |
| Hologic, Inc. | 679.8 Million USD | 56.325% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 21.926% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | 37.442% |
| Masimo Corporation | 545 Million USD | 45.523% |
| McKesson Corporation | 21.13 Billion USD | 98.595% |
| Patterson Companies, Inc. | 782.89 Million USD | 62.077% |
| Quest Diagnostics Incorporated | 190 Million USD | -56.264% |
| ResMed Inc. | 822.25 Million USD | 63.892% |
| Henry Schein, Inc. | 1.81 Billion USD | 83.642% |
| Teladoc Health, Inc. | 29.51 Million USD | -906.004% |
| Universal Health Services, Inc. | 216.98 Million USD | -36.829% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 89.486% |
| Becton, Dickinson and Company | 3.27 Billion USD | 90.929% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 75.676% |
| Danaher Corporation | 2.59 Billion USD | 88.554% |
| Stryker Corporation | 4.84 Billion USD | 93.869% |
| Medtronic plc | 5.21 Billion USD | 94.309% |